{
    "eid": "2-s2.0-85124895698",
    "title": "The Efficacy of Early Additional Hemoperfusion Therapy for Severe COVID-19 Patients: A Prospective Cohort Study",
    "cover-date": "2022-11-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Hematology",
            "@code": "2720",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Nephrology",
            "@code": "2727",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [
        "Hemoperfusion therapy",
        "Severe COVID-19",
        "Survival"
    ],
    "authors": [
        "Karjbundid Surasit",
        "Nattachai Srisawat"
    ],
    "citedby-count": 7,
    "ref-count": 17,
    "ref-list": [
        "Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China",
        "Cytokine storm",
        "Dexamethasone in hospitalized patients with Covid-19",
        "Haemoperfusion should only be used for COVID-19 in the context of randomized trials",
        "A new series of sorbent devices for multiple clinical purposes: current evidence and future directions",
        "Surviving sepsis campaign guidelines on the management of adults with coronavirus disease 2019 (COVID-19) in the ICU: first update",
        "Modified chest X-ray scoring system in evaluating severity of COVID-19 patient in Dr. Soetomo General Hospital Surabaya, Indonesia",
        "SARS-CoV-2 and viral sepsis: observations and hypotheses",
        "Extracorporeal blood purification and organ support in the critically ill patient during COVID-19 pandemic: expert review and recommendation",
        "Efficacy of HA330 hemoperfusion adsorbent in patients followed in the intensive care unit for septic shock and acute kidney injury and treated with continuous venovenous hemodiafiltration as renal replacement therapy",
        "Hemoperfusion as a potential treatment for critically ill COVID-19 patients with cytokine storm",
        "Early hemoperfusion for cytokine removal may contribute to prevention of intubation in patients infected with COVID-19",
        "Polymyxin B hemoperfusion in COVID-19 patients with endotoxic shock: case series from EUPHAS II registry",
        "Cytokine adsorption in patients with severe COVID-19 pneumonia requiring extracorporeal membrane oxygenation (CYCOV): a single centre, open-label, randomised, controlled trial"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60002620",
            "affilname": "Faculty of Medicine, Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002620",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Chaing Mai",
            "@id": "60031637",
            "affilname": "Nakornping Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60031637",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60022183",
            "affilname": "King Chulalongkorn Memorial Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022183",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "102044311",
            "affilname": "Academy of Science",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/102044311",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": [
        "King Chulalongkorn Memorial Hospital"
    ]
}